Denosumab OÜ
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
-Registered
11/02/2019Share capital
2,500.00 €Contacts
Company registration address
Copy
Website
-
Pre-Score
D
LowReliability
D - LowNumber of employees
No data availableCredit limit
No data availableCredit report
Company's financial performance and creditability assessment.
0 ** during past year
Taxes
151Debts
-Taxable turnover
No data available
Name, Surname  | Title | Start date | End date | Linkages |
|---|---|---|---|---|
Data is only provided to registered users with a legitimate interest. |
Financial ratios
Net Profit (€)
Enjoy unlimited use
with Freemium unlimited
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
Register and
explore Okredo dataEBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| 2022 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| - |
| 0 |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| - |
| 0 |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| - |
| 0 |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| 0 |
| - |
| 0 |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
Enjoy unlimited use
with Freemium unlimitedEnjoy unlimited use
with Freemium unlimitedCredit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Example report (PDF)
Similar companies
Category:
Other retail sale in non-specialised storesComp. code:
16747698Reg. date:
29/05/2023Turnover:
-No. of employees:
1Category:
Other retail sale in non-specialised storesComp. code:
16587645Reg. date:
06/10/2022Turnover:
-No. of employees:
2Category:
Other retail sale in non-specialised storesComp. code:
16558690Reg. date:
23/08/2022Turnover:
-No. of employees:
1Category:
Other retail sale in non-specialised storesComp. code:
16245717Reg. date:
04/06/2021Turnover:
-No. of employees:
1Category:
Other retail sale in non-specialised storesComp. code:
16165341Reg. date:
19/02/2021Turnover:
-No. of employees:
1Description
CopyAbout Denosumab OÜ
Denosumab OÜ is a registered company in Estonia. It was incorporated on 11/02/2019 and is registered under company number 14659352. Its registered office is located at Harju maakond, Tallinn, Kristiine linnaosa, Keemia tn 4. The company's registered activity is Other retail sale in non-specialised stores (47191 - EMTAK 2008).Frequently Asked Questions
What is the current status of Denosumab OÜ?
Denosumab OÜ is currently Registered. It was registered on 11/02/2019.
Where is Denosumab OÜ located?
Denosumab OÜ is registered at Harju maakond, Tallinn, Kristiine linnaosa, Keemia tn 4.
What does Denosumab OÜ do?
Denosumab OÜ operates in the Other retail sale in non-specialised stores (47191 - EMTAK 2008) sector.
What is the annual turnover of Denosumab OÜ?
Denosumab OÜ reported a turnover of 0 EUR in 2024.
What is the net profit of Denosumab OÜ?
Denosumab OÜ reported a net profit of 0 EUR in 2024.
Is Denosumab OÜ a reliable company?
Denosumab OÜ Pre-Score* rating is D, which indicates a low level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.Does Denosumab OÜ have any unpaid debts?
Denosumab OÜ has no recorded unpaid debts.